Ceragenix Pharmaceuticals

Colorado business, 5/2
Denver Post - Ceragenix Pharmaceuticals Inc. , a Denver-based biopharmaceutical company, announced Monday that Steven Porter, its chairman and chief executive, will make a presentation at the Rodman & Renshaw third annual Global Healthcare Conference on May 15 in

Research on Use of Ceragenins(TM) As Potential Therapy for Cystic
MSN MoneyCentral - Ceragenix Pharmaceuticals, Inc. a biopharmaceutical company focused on infectious disease and dermatology, today announced that the American Society of Microbiology ("ASM") has accepted nine research abstracts on Ceragenins(TM) as poster

Innovations & ideas, 7/2
Denver Post - A Denver-based biotechnology company is looking at ways to treat eczema in children without using steroids. Ceragenix Pharmaceuticals Inc. said last week that it will begin a study of its topical cream Epiceram to see if it works just as well on

Ceragenix Pharmaceuticals, Inc. CEO Featured in Exclusive
MSN MoneyCentral - NEW YORK, July 13 /PRNewswire-FirstCall/ -- On July 12, Steven Porter, CEO of Ceragenix Pharmaceuticals, Inc. (OTC Bulletin Board: CGXP) updated the investment community in an exclusive interview with www.wallst.net . Topics covered in the interview